title: Has "levodopa-induced neuropathy" been reported in Parkinson's disease clinical trials?
authors.forename: Tiago
authors.initials: T
authors.lastname: Teodoro
authors.forename: Daniela
authors.initials: D
authors.lastname: Pires
authors.forename: Mário M
authors.initials: MM
authors.lastname: Rosa
authors.forename: Miguel
authors.initials: M
authors.lastname: Coelho
authors.forename: Cristina
authors.initials: C
authors.lastname: Sampaio
authors.forename: Joaquim J
authors.initials: JJ
authors.lastname: Ferreira
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa